Acceptance Testing of Used Cascade Impactor Stages Based on Pressure Drop Measurements in a Flow System Managed with a Critical Flow Venturi: Part I—Laboratory Proof-of-Principle-Reference-Cited by-同舟云学术

Acceptance Testing of Used Cascade Impactor Stages Based on Pressure Drop Measurements in a Flow System Managed with a Critical Flow Venturi: Part I—Laboratory Proof-of-Principle

Published:2023-11-29 Issue: Volume: Page:
ISSN:1941-2711
Container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery
language:en
Short-container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery

Author:

Roberts Daryl L.¹^ORCID

Affiliation:

1. Applied Particle Principles, LLC, Hamilton, Virginia, USA.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmaceutical Science,Pulmonary and Respiratory Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/jamp.2023.0035

Reference19 articles.

1. 1. US Pharmacopeial Convention, United States Pharmacopeia 41/National Formulary 36 1S. Chapter <601> Aerosols, nasal sprays, metered-dose inhalers and dry powder inhalers. USP: Rockville, MD, USA; 2021.

2. 2. European Directorate for Quality in Medicines and Healthcare (EDQM). European Pharmacopoeia 11.0, monograph 2.9.18. Preparations for inhalation: Aerodynamic assessment of fine particles. EDQM: Strasbourg, France; 2023.

3. Cascade Impactor (CI) Mensuration—An Assessment of the Accuracy and Precision of Commercially Available Optical Measurement Systems

4. A Microorifice Uniform Deposit Impactor (MOUDI): Description, Calibration, and Use

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acceptance Testing of Used Cascade Impactor Stages Based on Pressure Drop Measurements in a Flow System Managed with a Critical Flow Venturi: Part II—Quantification of the Test Uncertainty Ratio for Pass/Fail Decision-Making under Pharmacopeial Constraints;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2023-11-29